Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia

por Kuželová, Kateřina, Brodská, Barbora, Fuchs, Ota, Dobrovolná, Marie, Soukup, Petr, Cetkovský, Petr
Publicado 2015

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel

por Šestáková, Šárka, Cerovská, Ela, Šálek, Cyril, Kundrát, Dávid, Ježíšková, Ivana, Folta, Adam, Mayer, Jiří, Ráčil, Zdeněk, Cetkovský, Petr, Remešová, Hana
Publicado 2022

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy

por Pavlík, Tomáš, Janoušová, Eva, Pospíšil, Zdeněk, Mužík, Jan, Žáčková, Daniela, Ráčil, Zdeněk, Klamová, Hana, Cetkovský, Petr, Trněný, Marek, Mayer, Jiří, Dušek, Ladislav
Publicado 2011

CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

por Hájková, Hana, Fritz, Markus Hsi-Yang, Haškovec, Cedrik, Schwarz, Jiří, Šálek, Cyril, Marková, Jana, Krejčík, Zdeněk, Dostálová Merkerová, Michaela, Kostečka, Arnošt, Vostrý, Martin, Fuchs, Ota, Michalová, Kyra, Cetkovský, Petr, Beneš, Vladimír
Publicado 2014

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels

por Klamová, Hana, Poláková, Kateřina Machová, Mužík, Jan, Ráčil, Zdeněk, Žáčková, Daniela, Steinerová, Kateřina, Karas, Michal, Faber, Edgar, Demečková, Eva, Michalovičová-Sninská, Zuzana, Voglová, Jaroslava, Demitrovičová, Ľudmila, Mikušková, Eva, Tóthová, Elena, Chudej, Juraj, Markuljak, Imrich, Cmunt, Eduard, Moravcová, Jana, Dvořáková, Dana, Michalová, Kyra, Jarošová, Marie, Šťastná, Markéta Marková, Cetkovský, Petr, DuŠek, Ladislav, Koza, Vladimír, Trněný, Marek, Indrák, Karel
Publicado 2013

Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study

por Kayser, Sabine, Kramer, Michael, Martínez-Cuadrón, David, Grenet, Justin, Metzeler, Klaus H., Sustkova, Zuzana, Luskin, Marlise R., Brunner, Andrew M., Elliott, Michelle A., Gil, Cristina, Marini, Sandra Casal, Ráčil, Zdeněk, Cetkovsky, Petr, Novak, Jan, Perl, Alexander E., Platzbecker, Uwe, Stölzel, Friedrich, Ho, Anthony D., Thiede, Christian, Stone, Richard M., Röllig, Christoph, Montesinos, Pau, Schlenk, Richard F., Levis, Mark J.
Publicado 2021